Skip to main content
Fig. 4 | Clinical and Translational Medicine

Fig. 4

From: Towards pathway-centric cancer therapies via pharmacogenomic profiling analysis of ERK signalling pathway

Fig. 4

Model of pathway-centric personalized medicine. Green and grey rectangles indicate drug effector and drug non-effector pathways, respectively; red and white circles represent individually altered and wildtype genes, respectively; normal and bold lines indicate normal and ectopic activated pathway signalling, respectively; and flash signs indicate drugs targeting specific molecules. One case with good drug effect, two cases with no drug effect, and two cases with partial drug effect are demonstrated.

Back to article page